Novo Nordisk A/S Income Statement Analysis

Revenue, earnings, and profit margins in billions DKK

Scroll to see more
Novo Nordisk A/S income statement - Annual data in billions DKK
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue309.06290.40232.26176.95140.80126.95122.02111.83
Cost of Revenue58.7944.5235.7728.4223.6620.9320.0917.62
Gross Profit250.28245.88196.50148.53117.14106.01101.9394.21
Operating Expenses
Research & Development52.0448.0632.4423.2617.207.4414.2214.81
Selling, General & Administrative70.2867.3861.6050.6841.0636.8935.8333.31
Operating Expenses122.62117.5493.9272.9157.9351.8950.0548.12
Operating Income127.66128.34102.5775.6259.2254.1351.8846.10
Other Income/Expense
Interest Income1.271.841.070.240.230.340.000.00
Interest Expense4.211.640.54-0.38-0.29-0.390.000.00
Other Income/Expense6.06-1.151.77-0.18-0.12-0.150.000.00
Income
Income Before Tax130.54127.19104.6769.0659.0852.9848.5547.62
Income Tax Expense28.1126.2020.9913.5411.3210.999.608.99
Net Income102.43100.9983.6855.5347.7641.9938.9538.63
Net Income - Continuous Operations102.43100.9983.6855.5347.760.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.000.00
EBITDA156.73137.38114.6381.1263.7758.570.000.00
EBIT134.75138.90105.2275.6259.2254.130.000.00
Depreciation & Amortization21.988.559.415.504.551.750.000.00
Earnings Per Share
Basic EPS23.0023.0019.0012.0021.0018.0016.00-
Diluted EPS23.0023.0019.0012.0021.0018.0016.00-
Basic Shares Outstanding4.444.454.484.530.000.000.000.00
Diluted Shares Outstanding4.454.464.494.540.000.000.000.00